Chief Translational Officer @ (January 2022 - October 2023)
Chief Translational Officer @ (January 2022 - September 2023)
Chief Translational Officer @ (January 2022 - June 2022)
Sr Vice President, Biology and Translational Genetics @ (July 2020 - January 2022)
Vice President of Immunology and Infectious Diseases @ (March 2019 - July 2020)
Principal Scientist, Department of Cancer Immunology @ (July 2015 - March 2019)
Director of Research and Head of Lab @ (December 2002 - January 2017)
Director of Immunology Department @ (December 2009 - July 2015)
Matthew Albert Education
Cornell University
Doctor of Medicine (Medicine)
1993-2000
Rockefeller University
Doctor of Philosophy (Immunology)
1993-2000
Brown University
(Chemistry)
1988-1992
Matthew Albert Skills
Molecular Biology
Cell Biology
Immunology
Lifesciences
Cell
Cell Culture
Flow Cytometry
Biochemistry
Biotechnology
Genomics
Genetics
Drug Discovery
Assay Development
Matthew Albert Summary
Matthew Albert, based in Emeryville, CA, US, is currently a Vice President, Translational Sciences and Early Clinical Development at Octant. Matthew Albert brings experience from previous roles at Hibio, HI-Bio: A Biogen Company, HIBio and INSERM. Matthew Albert holds a 1993 - 2000 Doctor of Medicine in Medicine @ Cornell University. With a robust skill set that includes Molecular Biology, Cell Biology, Immunology, Lifesciences, Cell and more. Matthew Albert has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Matthew Albert?
Find contact details for 700 million professionals.